<DOC>
	<DOCNO>NCT03017547</DOCNO>
	<brief_summary>Acute Respiratory Distress Syndrome ( ARDS ) patient randomize receive either IC14 ( single dose 4 mg/kg follow 2 mg/kg Days 2-4 ) placebo . Study participation total 28 day .</brief_summary>
	<brief_title>A Phase 2 Study IC14 Acute Respiratory Distress Syndrome</brief_title>
	<detailed_description>Up 160 patient ARDS randomize receive either IC14 dosage 4 mg/kg Study Day 1 , 2 mg/kg daily Study Days 2-4 placebo 4 day begin within 48 hour meet inclusion criterion . Study participation 28 day .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<criteria>1 . ICU admission 2 . Age 1870 year 3 . Presence known ARDS clinical risk within 7 day onset : 1 . Pneumonia 2 . Sepsis 3 . Trauma 4 . Aspiration 5 . Pancreatitis 4 . Presence ARDS ( per Berlin criterion ) define follow : 1 . Acute onset ( &lt; 48 hour ) 2 . PaO2/FiO2 &lt; 300 PEEP≥5 3 . Bilateral opacity consistent pulmonary edema frontal chest radiograph fully explain effusion , lobar/lung collapse , nodule . 4 . Requirement positive pressure ventilation via endotracheal tube 5 . Anticipated duration mechanical ventilation &gt; 48 hr 1 . Treatment drug device within last 30 day receive regulatory approval time study entry 2 . Intubation cardiopulmonary arrest 3 . Donotattempt resuscitation ( DNAR ) status 4 . Intubation status asthmaticus , pulmonary embolus , myocardial infarction 5 . Anticipated survival &lt; 48 hour intubation 6 . Anticipated survival &lt; 28 day due preexist medical condition 7 . Significant preexist organ dysfunction 1 . Lung : Currently receive home oxygen therapy document medical record 2 . Heart : Preexisting congestive heart failure define ejection fraction &lt; 20 % document medical record 3 . Renal : Chronic renal failure require renal replacement therapy 4 . Liver : Severe chronic liver disease define ChildPugh Class C 8 . Preexisting , ongoing immunosuppression 1 . Solid organ transplant recipient 2 . Chronic highdose corticosteroid ( equivalent &gt; 20 mg/prednisone/day &gt; 14 day last 30 day ) 3 . Oncolytic drug therapy within past 14 day 4 . Known HIV positive CD4 count &lt; 200 cells/mm3 9 . Current treatment Enbrel® ( etanercept ) , Remicade® ( infliximab ) , Humira® ( adalimumab ) , Cimzia® ( certolizumab ) , Simponi® ( golimumab ) , Kineret® ( anakinra ) , Arcalyst® ( rilonacept ) 10 . Pregnancy 11 . History hypersensitivity idiosyncratic reaction IC14 12 . Deprivation freedom administrative court order</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>